Hemoglobin compositions

MY214829AActive Publication Date: 2026-08-18PROLONG PHARMACEUTICALS LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2023005455
Authority / Receiving Office
MY · MY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2009-06-09
Filing Date
2010-06-09
Publication Date
2026-08-18
Estimated Expiration
2030-06-09
Patent Text Reader

Abstract

The invention provides compositions containing hemoglobin, particularly PEGylated hemoglobin. The PEGylated hemoglobin molecule is capable of transferring oxygen or carbon monoxide bound thereto to a tissue with which it is in proximity. Exemplary PEGylated hemoglobin formulations of the invention are virally inactivated. Various compositions of the invention include deoxygenated hemoglobin, which may be conjugated with one or more water-soluble polymer. PEGylated hemoglobin includes those species in which the iron atom of the hemoglobin molecule is not bound to oxygen or any other species, and hemoglobin molecules in which a species other than oxygen, e.g., carbon monoxide, is bound to the iron atom. The compositions of the invention are formulated as hypo-, iso- or hypertonic solutions of the PEGylated hemoglobin. The compositions are of use to treat and / or ameliorate disease, injury and insult by providing for the oxygenation of tissues and / organs. FIGURE 1
Need to check novelty before this filing date? Find Prior Art